ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $251,000 | -71.0% | 8,920 | -66.1% | 0.03% | -61.4% |
| Q3 2021 | $865,000 | +26.3% | 26,345 | +34.9% | 0.09% | +14.3% |
| Q2 2021 | $685,000 | +161.5% | 19,536 | +140.7% | 0.08% | -47.3% |
| Q2 2020 | $262,000 | +14.4% | 8,115 | +44.1% | 0.15% | +156.1% |
| Q1 2020 | $229,000 | -35.1% | 5,630 | -1.6% | 0.06% | +39.0% |
| Q4 2019 | $353,000 | -47.9% | 5,723 | -38.5% | 0.04% | -55.4% |
| Q3 2019 | $678,000 | -67.2% | 9,299 | -63.0% | 0.09% | -60.3% |
| Q2 2019 | $2,067,000 | +23.2% | 25,148 | +5.7% | 0.23% | +36.5% |
| Q1 2019 | $1,678,000 | +25.9% | 23,795 | -19.6% | 0.17% | +10.4% |
| Q4 2018 | $1,333,000 | -7.6% | 29,600 | +16.1% | 0.15% | +92.5% |
| Q3 2018 | $1,442,000 | -15.7% | 25,500 | -0.4% | 0.08% | -5.9% |
| Q2 2018 | $1,710,000 | +314.0% | 25,600 | +260.6% | 0.08% | +286.4% |
| Q1 2018 | $413,000 | -18.9% | 7,100 | -10.1% | 0.02% | -29.0% |
| Q4 2017 | $509,000 | -4.0% | 7,900 | -21.8% | 0.03% | -13.9% |
| Q3 2017 | $530,000 | -81.6% | 10,100 | -82.7% | 0.04% | -76.8% |
| Q1 2017 | $2,887,000 | -11.4% | 58,310 | +8.5% | 0.16% | -20.5% |
| Q4 2016 | $3,259,000 | -10.4% | 53,754 | -1.9% | 0.20% | 0.0% |
| Q3 2016 | $3,637,000 | -6.5% | 54,810 | -21.4% | 0.20% | -9.3% |
| Q2 2016 | $3,891,000 | +74.2% | 69,710 | +5.1% | 0.22% | +51.4% |
| Q1 2016 | $2,233,000 | -10.8% | 66,346 | +19.7% | 0.14% | +16.4% |
| Q4 2015 | $2,502,000 | +26.6% | 55,447 | +10.8% | 0.12% | +25.8% |
| Q3 2015 | $1,977,000 | +17.1% | 50,027 | +83.9% | 0.10% | +49.2% |
| Q2 2015 | $1,688,000 | -41.0% | 27,202 | -40.5% | 0.06% | -43.0% |
| Q1 2015 | $2,860,000 | +10.9% | 45,727 | -0.1% | 0.11% | -36.7% |
| Q4 2014 | $2,580,000 | +84.8% | 45,754 | -7.3% | 0.18% | +146.6% |
| Q3 2014 | $1,396,000 | +34.9% | 49,354 | +64.2% | 0.07% | +55.3% |
| Q2 2014 | $1,035,000 | – | 30,054 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 328,494 | $15,137,000 | 4.72% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $13,824,000 | 2.78% |
| Mesirow Financial Investment Management, Inc. | 12,277 | $566,000 | 1.63% |
| Parkman Healthcare Partners LLC | 137,226 | $6,323,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 284,831 | $13,125,000 | 1.27% |
| Stonepine Capital Management, LLC | 52,290 | $2,410,000 | 1.11% |
| 1492 Capital Management LLC | 43,611 | $2,010,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,770 | $3,445,000 | 0.81% |
| Walthausen & Co., LLC | 61,456 | $2,832,000 | 0.74% |
| Rubric Capital Management LP | 307,557 | $14,172,000 | 0.67% |